Abvc Biopharma (ABVC) Net Income Attributable to Noncontrolling Interests (2018 - 2026)
Abvc Biopharma (ABVC) reported Net Income Attributable to Noncontrolling Interests of -$2.54 million for Q3 2026, compared with -$41,010 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Net Income Attributable to Noncontrolling Interests (2018 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Abvc Biopharma's Net Income Attributable to Noncontrolling Interests came in at -$2.99 million; for FY2025, it was -$468,405.
- By year, Net Income Attributable to Noncontrolling Interests came in at -$356,159 in FY2024, -$492,794 in FY2023, $110,865 in FY2022 (-86.2%) and $802,962 in FY2021.
- The Q3 2026 figure ranks as the lowest quarterly Net Income Attributable to Noncontrolling Interests in data going back to Q1 2018.
- Per Business Quant data, the three quarters before Q3 2026 came in at -$73,547 (Q2 2026), -$129,695 (Q1 2026) and -$249,469 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | -2.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.54 Mn |
| Jun 30, 2026 | -73,547.00 |
| Mar 31, 2026 | -129,695.00 |
| Dec 31, 2025 | -249,469.00 |
| Sep 30, 2025 | -41,010.00 |
| Jun 30, 2025 | -75,811.00 |
| Mar 31, 2025 | -102,115.00 |
| Dec 31, 2024 | -64,953.00 |
| Sep 30, 2024 | -92,662.00 |
| Jun 30, 2024 | -105,076.00 |
| Mar 31, 2024 | -93,468.00 |
| Dec 31, 2023 | -316,981.00 |
| Sep 30, 2023 | -50,564.00 |
| Jun 30, 2023 | -51,714.00 |
| Mar 31, 2023 | -73,535.00 |
| Dec 31, 2022 | 363,036.00 |
| Sep 30, 2022 | -71,660.00 |
| Jun 30, 2022 | -88,336.00 |
| Mar 31, 2022 | -92,175.00 |
| Dec 31, 2021 | 1.03 Mn |
API Access
Abvc Biopharma Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();